Gene therapy for cardiovascular diseases

Journal of Nuclear Cardiology

Volumn 6, Issue 1, 1999, Pages 69-75

  Nabel, Elizabeth G ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; LIPID; OLIGONUCLEOTIDE; PLASMID DNA; PLASMID VECTOR; RECOMBINANT PROTEIN; RIBOZYME; VASCULOTROPIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ANGIOGENESIS; ANIMAL MODEL; CARDIOVASCULAR DISEASE; CATHETERIZATION; CLINICAL TRIAL; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEART MUSCLE CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW;

EID: 0033040315     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(99)90066-1     Document Type: Article

References (5)

1. Nabel EG. Gene therapy for cardiovascular disease. Circulation 1995;91:541-8.
2. Mulligan RC. The basic science of gene therapy. Science 1993;260:926-32.
3. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995;270:404-10.
4. Leiden JM. Gene therapy - promise, pitfalls, and prognosis. N Engl J Med 1995;333:871-3.
5. Ohno T, Gordon D, San H, et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994;265:781-4.